Prevention of Incisional Hernia After Elective Open Abdominal Aortic Aneurysm (AAA) Repair
NCT ID: NCT01189708
Last Updated: 2023-09-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
9 participants
INTERVENTIONAL
2008-03-31
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients scheduled for elective open abdominal aortic aneurysm repair will be randomized into two groups, one receiving an onlay mesh, the other conventional wound closure with sutures.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevention of Incisional Hernia by Mesh Augmentation After Midline Laparotomy for Aortic Aneurysm Treatment
NCT00757133
Prophylactic Mesh Reinforcement After Open Aortic Aneurysm Repair
NCT06762561
Intraperitoneal Mesh-Implementation After Laparotomy
NCT01003067
Aneurysma Hernia Study - Incidence of Incisional Hernias After Abdominal Aortic Aneurysm Repair
NCT02012270
Prophylactic Mesh Implantation for the Prevention of Incisional Hernia
NCT01203553
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Arm 1: Abdominal wall will be closed with a prophylactic mesh implantation in onlay technique after elective open abdominal aortic aneurysm repair.
Arm 2: Abdominal wall will be closed with standard sutures (without mesh implantation)
After the patients gave their informed consent to participate in the study, they will be randomized to one of the two treatment arms. Allocation is carried out based on a prepared randomization list.
Primary endpoint is the rate of incisional hernias within the follow-up period of 2 years. Secondary endpoints are postoperative complications and adverse events during the follow-up period.
Study enrollment was prematurely terminated on 30. Apr 2009. Already enrolled patients will be followed for 24 months according to protocol.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mesh implantation
Ultrapro® Mesh implantation
Ultrapro® Mesh implantation
After the aortic procedure (aortic aneurysm repair) an Ultrapro absorbable mesh will be used for the wound closure of the abdominal wall using an onlay technique.
Standard wound closure without a mesh
Standard wound closure
Standard wound closure
Abdominal closure will be performed with standard sutures without a mesh.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrapro® Mesh implantation
After the aortic procedure (aortic aneurysm repair) an Ultrapro absorbable mesh will be used for the wound closure of the abdominal wall using an onlay technique.
Standard wound closure
Abdominal closure will be performed with standard sutures without a mesh.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* EVAR (endovascular procedure)
* Patients with previous midline laparotomy
* Patients with in situ abdominal mesh after previous hernia repair
* Patients with large diastasis of abdominal wall
* Allergy to penicillin
* Women before menopause (mesh can interfere with potential future pregnancies)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cantonal Hospital of St. Gallen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ignazio Tarantino
M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wolfgang Nagel, MD
Role: PRINCIPAL_INVESTIGATOR
KSSG
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kantonsspital St. Gallen, Department of Surgery
Sankt Gallen, Canton of St. Gallen, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EKSG08/006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.